265 related articles for article (PubMed ID: 7814893)
1. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction.
Roberge FG; Xu D; Chan CC; de Smet MD; Nussenblatt RB; Chen H
Curr Eye Res; 1993 Feb; 12(2):197-203. PubMed ID: 8449029
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats.
Mochizuki M; Nussenblatt RB; Kuwabara T; Gery I
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):226-32. PubMed ID: 3871750
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
5. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
7. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
[TBL] [Abstract][Full Text] [Related]
8. Precipitation of experimental autoallergic uveoretinitis by cyclosporin A withdrawal: an experimental model of uveitis relapse.
Atkinson EG; Dinning WJ; Kasp E; Graham EM; Dumonde DC
Clin Exp Immunol; 1989 Oct; 78(1):108-14. PubMed ID: 2805414
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacological studies of qingkaining, a Chinese blended medicine: effects on experimental autoimmune uveoretinitis in the rat.
Ni M; Chan CC; Mao W; Nussenblatt RB
Immunol Invest; 1989 Aug; 18(7):907-17. PubMed ID: 2793211
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effects of polynactins (tetranactin, trinactin and dinactin) on experimental autoimmune uveoretinitis in rats.
Tanouchi Y; Shichi H
Jpn J Ophthalmol; 1987; 31(2):218-29. PubMed ID: 3499534
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Mochizuki M; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Kaku H; Inaba G
Jpn J Ophthalmol; 1989; 33(4):425-40. PubMed ID: 2625778
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.
Palestine AG; Muellenberg-Coulombre CG; Kim MK; Gelato MC; Nussenblatt RB
J Clin Invest; 1987 Apr; 79(4):1078-81. PubMed ID: 3494043
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine on T-cell subsets in experimental autoimmune uveitis.
Nussenblatt RB; Scher I
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):10-4. PubMed ID: 3871429
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
15. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
Nussenblatt RB; Caspi RR; Mahdi R; Chan CC; Roberge F; Lider O; Weiner HL
J Immunol; 1990 Mar; 144(5):1689-95. PubMed ID: 2137841
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
Caspi RR; McAllister CG; Gery I; Nussenblatt RB
Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis.
Chan CC; Palestine AG; Nussenblatt RB
Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):867-70. PubMed ID: 6234255
[TBL] [Abstract][Full Text] [Related]
20. Effects of bucillamine, a new anti-rheumatic drug, on the experimental autoimmune uveitis in rats.
Sawa K; Mochizuki M
Exp Eye Res; 1994 Apr; 58(4):431-8. PubMed ID: 7925680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
